Central nervous system stimulants and drugs which suppress appetite

Romagnoli, 1992, Effectiveness and side effects of two different doses of caffeine in preventing apnea in premature infants, Ther. Drug Monit., 14, 14, 10.1097/00007691-199202000-00003 Hughes, 1991, Caffeine self administration, withdrawal and adverse effects among coffee drinkers, Arch. Gen. Psychiatry, 48, 611, 10.1001/archpsyc.1991.01810310029006 Hughes, 1992, Should caffeine abuse, dependence or withdrawal be added to DSM-IV and ICD-10, Am. J. Psychiatry, 149, 33, 10.1176/ajp.149.1.33 Kunkel, 1991, Chemical abuse in the head-ache patient, Pain Management, July/ August, 27 Glore, 1991, Trigeminal neuralgia: case study of pain cessation with a low-caffeine diet, J. Am. Diet. Assoc., 91, 1120 Cohen, 1992, Grand mal seizure in a postpartum patient following intravenous infusion of caffeine sodium benzoate to treat persistent headache, J. Clin. Anesth., 4, 48, 10.1016/0952-8180(92)90121-G Fried, 1992, The effect of filtered coffee consumption on plasma lipid levels. Results of a randomized clinical trial, J. Am. Med. Assoc., 267, 811, 10.1001/jama.1992.03480060057030 Hendeles, 1992, Safety and efficacy of theophylline in children with asthma, J. Pediatr., 120, 177, 10.1016/S0022-3476(05)80423-8 1991 Tsiu, 1990, Theophylline toxicity: update, Ann. Allergy, 64, 241 Belfer, 1992, Aminophylline in the emergency department, Curr. Opin. Pediatr., 4, 451, 10.1097/00008480-199206000-00011 Wrenn, 1991, Aminophylline therapy for acute bronchospastic disease in the emergency room, Ann. Intern. Med., 115, 241, 10.7326/0003-4819-115-4-241 Littenburg, 1988, Aminophylline treatment in severe acute asthma, a meta analysis, J. Am. Med. Assoc., 259, 1678, 10.1001/jama.1988.03720110040032 Hendeles, 1992, Safety and efficacy of theophylline in children with asthma, J. Pediatr., 120, 177, 10.1016/S0022-3476(05)80423-8 Minotti, 1992, Once-a-day dosing with theophylline: a comparison of four sustained-release products, Ann. Allergy, 68, 500 Gotz, 1991, Multizentrische studie mit großer Patientenzahl zur Bestatitung pharmacokinetischer und klinischer Befunde zu Euphylong aus kontrollierten Studien mit kleinen Patientenkollektiven, Pulmonologie, 45, 867 Martin, 1992, Overnight theophylline concentrations and effect on sleep and lung function in chronic obstructive pulmonary disease, Am. Rev. Respir. Dis., 145, 540, 10.1164/ajrccm/145.3.540 Perrotin, 1988, Survenue de crises convulsives sous theophylline a doses therapeutiques, Presse Med., 17, 1206 Bahls, 1991, Theophylline associated seizures with therapeutic or low toxic serum concentrations. Risk factors for serious outcome in adults, Neurology, 41, 1309, 10.1212/WNL.41.8.1309 Hendeles, 1991, Theophylline and seizures, Neurology, 42, 2054, 10.1212/WNL.42.10.2054-b Mori, 1992, Unilateral brain damage after prolonged hemiconvulsions in the elderly associated with theophylline administration, J. Neurol., Neurosurg. Psychiatry, 55, 466, 10.1136/jnnp.55.6.466 Dragunow, 1990, Adenosine receptor antagonism accounts for the seizure-prolonging effects of aminophylline, Pharmacol. Biochem. Behav., 36, 751, 10.1016/0091-3057(90)90072-P Pranzatelli, 1992, Acute dyskinesias in young asthmatics treated with theophylline, Pediatr. Neurol., 7, 216, 10.1016/0887-8994(91)90088-3 Ferreyros, 1992, Dyskinesia secondary to aminophylline, Pediatr. Neurol., 8, 157, 10.1016/0887-8994(92)90043-X Lindgren, 1992, Does asthma or treatment with theophylline limit children's academic performance?, New Engl J. Med., 327, 926, 10.1056/NEJM199209243271305 Bender, 1992, Theophylline induced behavior change in children, J. Am. Med Assoc., 267, 2621, 10.1001/jama.1992.03480190063032 Ueda, 1992, Aminophylline suppository induced acute proctitis, Am. J. Gastroenterol., 87, 889 Sinues, 1991, Cytogenetic study in peripheral blood lymphocytes from asthmatic patients receiving continued therapy with theophylline, Mutat. Res., 280, 271, 10.1016/0165-1218(92)90057-7 Wulff, 1990, Monitoring of genotoxic exposure of humans by the sister chromatid exchange test: methodology and confounding factors, Dan. Med. Bull., 37, 132 Minton, 1991, Pharmacodynamic interactions between infused adenosine and oral theophylline, Hum. Exp. Toxicol., 10, 411, 10.1177/096032719101000608 Grasela, 1992, An evaluation of the quinolone-theophylline interaction using the Food and Drug Administration Spontaneous Reporting System, Arch. Intern. Med., 152, 617, 10.1001/archinte.1992.00400150127023 O'Mahony, 1991, Cystic fibrosis and seizures, Lancet, 338, 259, 10.1016/0140-6736(91)90403-C Sperber, 1991, Toxic interactions between fluvoxamine and sustained release theophylline in an 11 year old boy, Drug Saf., 6, 460, 10.2165/00002018-199106060-00006 Ellison, 1992, Three fold increase in theophylline serum concentrations after the addition of mexiletine, J. Emerg. Med., 10, 506 Kendall, 1992, Theophylline-mexiletine interaction: a case report, Pharmacotherapy, 12, 416 Stoysich, 1991, Influence of mexiletine on the pharmacokinetics of theophylline in healthy volunteers, J. Clin. Pharmacol., 31, 354, 10.1002/j.1552-4604.1991.tb03717.x Ueno, 1991, Mechanism of interaction between theophylline and mexiletine, Drug Intelligence and Clinical Pharmacology, Ann. Pharmacother., 25, 727 Lee, 1992, Theophylline toxicity after propafenone treatment: evidence for drug interactions, Clin. Pharmacol. Ther., 51, 353, 10.1038/clpt.1992.32 Kamada, 1992, Effect of low dose troleandomycin on theophylline clearance: implications for therapeutic drug monitoring, Pharmacotherapy, 12, 98 Terzian, 1992, Aminophylline hypersensitivity due to ethylene diamine, Ann. Emerg. Med., 21, 312, 10.1016/S0196-0644(05)80895-9 Goldgrub, 1992, Therapeutic activity and tolerability profile of acebrophylline, Adv. Ther., 9, 107 Ferri, 1991, Exanthime induit par la bamifylline, Ann. Dermatol. Venereol., 118, 635 De Benedetto, 1991, Effetti cardiorespiratori dell'infusione endovenosa dei derivati xanthinici. Valutazione mediante monitoraggio degli scambi gassosi e dell'eletrocardiogramma dinamico in pazienti COPD, Ital. J. Chest Dis., 45, 353 Dini, 1991, Chronotropic and arrhythmogenic effects of two methylxanthine bronchodilators, doxofylline and theophylline, evaluated by Holter monitoring, Curr. Ther. Res., 49, 978 Melillo, 1989, Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicenter trial, Int. J. Clin. Pharmacol. Res., 9, 397 Cirillo, 1988, Doxofylline, an antiasthmatic drug lacking affinity for adenosine receptors, Arch. Int. Pharmacodyn. Ther., 295, 221 Saletu, 1990, Propentofylline in adult-onset cognitive disorders: double blind, placebo-controlled, clinical, psychometric and brain-mapping studies, Neuropsychobiology, 24, 173, 10.1159/000119482 Parnetti, 1991, Aniracetam (Ro-13-5057) for the treatment of senile dementia of Alzheimer type: results of a multicentric clinical study, Dementia, 2, 262 Bottini, 1992, Oxiracetam in dementia: a double-blind placebo-controlled study, Acta Neurol. Scand., 86, 237, 10.1111/j.1600-0404.1992.tb05077.x Rozzini, 1991, Effectiveness of oxiracetam therapy in the treatment of cognitive deficiencies secondary to primary degenerative dementia, Acta Neurol., 14, 117 Falsaperla, 1990, Selegeline versus oxiracetam in patients with Alzheimer type dementia, Clin. Ther., 12, 376 Marini, 1992, Placebo-controlled double blind study of pramiracetam (CI-879) in the treatment of elderly subjects with memory impairment, Adv. Ther., 9, 136 Durand, 1992, Fipexide-induced fulminant hepatitis. Report of three cases with emergency liver transplantation, J. Hepatol., 15, 144, 10.1016/0168-8278(92)90027-M Mion, 1990, Hepatite aigui medicamenteuse: un cas de cytolyse aigui apres prise de fipexide, Gastroenterol. Clin. Biol., 14, 513 Rosenburg, 1991, Methylphenidate in depressed medically ill patients, J. Clin. Psychiatry, 52, 263 Johnson, 1992, Methylphenidate in stroke patients with depression, Am. J. Phys. Med. Rehabil., 71, 239, 10.1097/00002060-199208000-00008 Levin, 1991, Psychostimulants for depression, Am. Fam. Phys., 44, 762 Fawcett, 1991, CNS stimulant potentiation of monoamine oxidase inhibitors, J. Clin. Psychopharmacol., 11, 127, 10.1097/00004714-199104000-00010 Marchioni, 1991, Diagnosis and management of attention deficit disorder in children, Curr. Opin. Pediatr., 3, 981, 10.1097/00008480-199112000-00007 Schulz, 1991, Hyperkinetischessyndrom in Kindes und Jugendalter. Diagnostik und Therapie, Med. Monatsschr. Pharm., 14, 137 Brown, 1991, Treatment of attention deficit hyperactivity disorder. A critical review, Drug Intelligence and Clinical Pharmacology. Ann. Pharmacother., 25, 1207 Di Traglia, 1991, Methylphenidate protocol: feasibility in a pediatric practice, Clin. Pediatr., 30, 660, 10.1177/000992289103001201 Handen, 1991, Adverse side effects of methylphenidate among mentally retarded children with ADHD, J. Am. Acad. Child Adolesc. Psychiatry, 30, 241, 10.1097/00004583-199103000-00012 Cohen, 1992, Fixed drug eruption of the scrotum due to methylphenidate, Ann. Pharmacother., 26, 1378, 10.1177/106002809202601107 Weinshenker, 1992, A double blind randomized cross over trial of pemoline in fatigue associated with multiple sclerosis, Neurology, 42, 1468, 10.1212/WNL.42.8.1468 Weintraub, 1992, Long term weight control study I (weeks 0 to 34), Clin. Pharmacol. Ther., 51, 586, 10.1038/clpt.1992.69 Weintraub, 1992, Long term weight control study II (Weeks 34 to 104), Clin. Pharmacol. Ther., 51, 595, 10.1038/clpt.1992.70 Weintraub, 1992, Long term weight control study III (Weeks 104 to 156), Clin. Pharmacol. Ther., 51, 602, 10.1038/clpt.1992.71 Weintraub, 1992, Long term weight control study IV (Weeks 156 to 190), Clin. Pharmacol. Ther., 51, 608, 10.1038/clpt.1992.72 Andersen, 1992, Dexfenfluramine as adjuvant to a low-calorie formula diet in the treatment of obesity: a randomized clinical trial, Int. J. Obesity, 16, 35 Silverstone, 1992, Centrally acting anorectic drugs: a clinical perspective, Am. J. Clin. Nutr., 55, 211S, 10.1093/ajcn/55.1.211s Guy-Grand, 1989, International trial of long-term dexfenfluramine in obesity, Lancet, 2, 1142, 10.1016/S0140-6736(89)91499-2 Guy-Grand, 1992, Clinical studies with fenfluramine, Am. J. Clin. Nutr., 55, 173S, 10.1093/ajcn/55.1.173s Bray, 1991, Barriers to the treatment of obesity, Ann. Intern. Med., 115, 152, 10.7326/0003-4819-115-2-152 Hirsch, 1991, Barriers to the treatment of obesity, Ann. Intern. Med., 115, 656, 10.7326/0003-4819-115-8-656_2 Paquot, 1991, Le traitement pharmacologique de l'obesité, Med. Hyg., 49, 3393 Pouwels, 1990, Pulmonary hypertension and fenfluramine, Eur. Respir. J., 3, 606 Atanassoff, 1992, Pulmonary hypertension and dexfenfluramine, Lancet, 339, 436, 10.1016/0140-6736(92)90129-Q Roche, 1992, Pulmonary hypertension and dexfenfluramine, Lancet, 339, 436, 10.1016/0140-6736(92)90129-Q Fotiadis, 1991, Fenfluramine induced irreversible pulmonary hypertension, Postgrad.. Med. J., 67, 776, 10.1136/pgmj.67.790.776-a Nall, 1991, Reversible pulmonary hypertension associated with anorexogenic use, Am. J. Med., 91, 97, 10.1016/0002-9343(91)90082-9 Gaul, 1982, Ein Fall von chronischer pulmonar Hypertonie nach Fenfluramineinnahme, Wien. Klin. Wochenschr., 22, 618 Loogen, 1985, Long-term follow-up of pulmonary hypertension in patients with and without anoretic drug intake, Cor Vasa, 27, 111 1991, Dexfenfluramine, Lancet, 337, 1315, 10.1016/0140-6736(91)92983-9 Bailie, 1991, Fenfluramine-induced unstable angina pectoris, Can. J. Hosp. Pharm., 44, 207 Garrattini, 1988, Progress in assessing the role of serotonin in the control of food intake, Clin. Neuropharmacol., 11, S8 Finer, 1992, Serotoninergic system: therapeutic implications in obesity, Acta Clin. Belg., 47, 47, 10.1080/17843286.1992.11718276 Zaczek, 1990, Effect of repeated fenfluramine administration on indexes of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data, J. Pharmacol. Exp. Ther., 253, 104 Molliver, 1990, An anatomic evidence of a neurotoxic effect of (±)fenfluramine upon serotoninergic projections in the rat, Brain Res., 511, 165, 10.1016/0006-8993(90)90237-6 Caccia, 1982, Species differences in the kinetics and metabolism of fenfluramine isomers, Arch. Int. Pharmacodyn. Ther., 258, 15 Ricaurte, 1991, Dexfenfluramine neurotoxicity in brains of non-human primates, Lancet, 338, 1487, 10.1016/0140-6736(91)92301-H Baumgarten, 1992, Dexfenfluramine and neurotoxicity, Lancet, 339, 359, 10.1016/0140-6736(92)91676-Y Blundell, 1992, Dexfenfluramine and neurotoxicity, Lancet, 339, 360 Kalia, 1992, Dexfenfluramine and neurotoxicity, Lancet, 339, 360 Nicolaidis, 1992, Dexfenfluramine and neurotoxicity, Lancet, 339, 360 Bories, 1992, Acute pancreatitis and dexfenfluramine (Isomeride): a case report, Gastroenterol. Clin. Biol., 16, 817 Aman, 1991, Fenfluramine and mental retardation, J. Am. Acad. Child Adolesc. Psychiatry, 30, 507, 10.1097/00004583-199105000-00027 Aman, 1989, Review of fenfluramine in the treatment of developmental disabilities, J. Am. Acad. Child Adolesc. Psychiatry, 28, 549, 10.1097/00004583-198907000-00014 Inoue, 1992, Clinical and basic aspects of an anorexiant, mazindol, as an anti obesity agent in Japan, Am. J. Clin. Nutr., 55, 199S, 10.1093/ajcn/55.1.199s Schteingart, 1992, Effectiveness of phenylpropanolamine in the management of moderate obesity, Int. J. Obesity, 16, 487 Sands, 1992, Effect of phenylpropanolamine hydrochloride on blood pressure in Korean patients with hypertension controlled by hydrochlorothiazide, Clin. Pharm., 11, 168 Dewsnap, 1992, A case of affective psychosis after routine use of proprietory cold remedy containing phenylpropanolamine, Hum. Exp. Toxicol., 11, 295, 10.1177/096032719201100412 Lake, 1991, Manic psychosis after coffee and phenyl propanolamine, Biol. Psychiatry, 30, 401, 10.1016/0006-3223(91)90296-X Brown, 1990, Organic affective psychosis associated with the routine use of nonprescription cold preparations, Br. J. Psychiatry, 156, 572, 10.1192/bjp.156.4.572 Amark, 1992, Effect of phenyl-propanolamine on incontinence in children with neurogenic bladders. A double-blind cross-over study, Acta Pediatr., 81, 345, 10.1111/j.1651-2227.1992.tb12240.x Veltri, 1992, Acute exposure to phenylpropanolamine: an analysis of 5447 cases reported to poison control centres from 1984–1987, Post Mark. Surveill., 6, 95 Beck, 1992, Cardiovascular effects of pseudoephedrine in medically controlled hypertensive patient, Arch. Intern. Med., 153, 1242, 10.1001/archinte.1992.00400180098015 Vial, 1992, First-trimester in utero exposure to anorectics: a French collaborative study with special reference to dexfenfluramine, Int. J. Risk Saf. Med., 3, 207, 10.3233/JRS-1992-3404 Chatellier, 1990, Tacrine (tetrahydroamino-acridine: THA) and lecithin in senile dementia of the Alzheimer's type, a multicentre trial, Br. Med. J., 300, 495, 10.1136/bmj.300.6723.495 Gauthier, 1990, Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate stage Alzheimer's disease: results of a Canadian double-blind, cross-over, multicenter study, New Engl. J. Med., 322, 1272, 10.1056/NEJM199005033221804 1991, An interim report from the FDA, New Engl. J. Med., 324, 349, 10.1056/NEJM199101313240526 Summers, 1991, An interim report from the FDA, New Engl. J. Med., 324, 352, 10.1056/NEJM199101313240527 Davis, 1992, A double blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease, New Engl. J. Med., 327, 1253, 10.1056/NEJM199210293271801 Ames, 1990, Heterogeneity of adverse hepatic reactions to tetrahydroaminoacridine, Aust. New Zealand J. Med., 20, 193, 10.1111/j.1445-5994.1990.tb01309.x Hammel, 1990, Acute hepatitis after tetrahydroaminoacridine administration for Alzheimer's disease, J. Clin. Gastroenterol., 12, 329, 10.1097/00004836-199006000-00021